
SpringTide Ventures is an early-stage health-tech venture capital firm founded in 2018 and headquartered in Cambridge, Massachusetts. The firm leads financings for healthcare companies across digital health, medical devices, life sciences, and tech-enabled care delivery.
33% of their portfolio is in Healthcare. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Average disclosed round size is $20.9M (across 37 rounds with reported amounts).
Portfolio
32
Fund Size
$65M
Top Stage
Seed
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
39 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| TTava | Series C | $40M | Apr 2026 |
| Series C | $40M | Apr 2026 | |
| Series D | $150M | Jan 2026 | |
| Series A | $14M | Dec 2025 | |
| Series A | $14M | Jan 2025 | |
| Series C | $150M | Oct 2024 | |
| Seed | $4M | Mar 2024 | |
| Series B | $20M | Mar 2024 | |
| Seed | $9.3M | Jan 2024 | |
| Seed | — | Sep 2023 | |
| Series A | $15M | Mar 2023 | |
| Seed | $3.3M | Jan 2023 | |
| BBinkey | Seed | $3.3M | Jan 2023 |
| Series A | $5M | Jul 2022 | |
| Series B | $27M | Jan 2022 | |
| NNetop | Seed | $4.5M | Jan 2022 |
| Series C | $75M | Dec 2021 | |
| PProlucent | Series A | $11.5M | Dec 2021 |
| Series A | $10M | Dec 2021 | |
| PPathologyWatch | Series B | $25M | Nov 2021 |
| Seed | $4M | Apr 2021 | |
| PProlucent | Series A | $11.5M | Jan 2021 |
| Seed | $5M | Jul 2020 | |
| Unknown | $24.1M | Jan 2020 | |
| Series A | $3.8M | Jan 2020 |
Page 1 of 2
Top Co-Investors
Alumni Ventures5 shared
UnityPoint Health Ventures4 shared
Peterson Ventures4 shared
Catalyst Investors3 shared
Blue Heron Capital3 shared
Dorm Room Fund3 shared
Stanford's StartX Fund3 shared
Health Velocity Capital3 shared
Airbus Ventures2 shared
DCVC2 shared
137 Ventures2 shared
Balerion Space Ventures2 shared
Overmatch Ventures2 shared
Tamarack Global2 shared
Elysium Venture Capital2 shared
Lux Capital2 shared
XTX Markets2 shared
Trousdale Ventures2 shared
Founders Fund2 shared
Gaingels2 shared
Last updated: 20 October 2026